Method for quantitatively determining specific constituting heparins or low molecular weight heparins using HPLC

Details for Australian Patent Application No. 2005223360 (hide)

Owner Aventis Pharma S.A.

Inventors Mourier, Pierre; Viskov, Christian

Agent Davies Collison Cave

Pub. Number AU-A-2005223360

PCT Pub. Number WO2005/090409

Priority 04290790.7 24.03.04 EP

Filing date 22 March 2005

Wipo publication date 29 September 2005

International Classifications

C08B 37/00 (2006.01) Preparation of polysaccharides not provided for in

G01N 30/00 (2006.01) Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography

Event Publications

31 August 2006 PCT application entered the National Phase

  PCT publication WO2005/090409 Priority application(s): WO2005/090409

9 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005223365-Method and device for producing threedimensional objects using laser technology and for applying an absorber using an ink jet method

2005223356-New compounds for the inhibition of angiogenesis and use of thereof